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The South African coloured population group comprises people whose 
ancestry is about 32 - 43% Khoisan, 20 - 36% black, 21 - 28% white 
and 9 - 11% Asian.1 This population has the second-highest prevalence 
of diabetes in South Africa, after that of the Indian population.2-4 
However, this finding was based on a study almost 20 years ago in 
a peri-urban coloured population of the Western Cape.2 Since then, 
South Africa has undergone significant political changes that have been 
accompanied by rapid urbanisation and economic changes, particularly 
among the coloured and other non-white population groups. These 
epidemiological changes are often paralleled by increases in lifestyle 
diseases such as dysglycaemia, obesity and high blood pressure that are 
associated with the metabolic syndrome (MetS).
MetS is common in subjects with type 2 diabetes, and is associated 
with micro- and macrovascular complications.5 In developing countries, 
type 2 diabetes is often undiagnosed, and related cardiovascular disease 
(CVD) risk may therefore far exceed that of known cases owing to the 
unmanaged glycaemic state and other risk factors.6 Studies of MetS 
in Africa and elsewhere have been hampered by differences in major 
sets of criteria for defining MetS.8 Recently, however, the International 
Diabetes Federation (IDF) and the American Heart Association/
National Heart, Lung and Blood Institute (AHA/NHLBI) released 
a consensus definition for MetS (the Joint Interim Statement (JIS) 
in which abdominal obesity was removed as a prerequisite for the 
diagnosis of metabolic syndrome.9 Consequently, the JIS definition 
classifies an individual as having MetS if 3 of the following criteria are 
met: raised blood pressure, elevated triglycerides, low high-density 
lipoprotein cholesterol levels, central obesity, and hyperglycaemia.
The last epidemiological report from South Africa on the 
prevalence of diabetes in the coloured population was 15 years ago, 
using the 1985 WHO criteria.2 We set out to establish the prevalence 
of diabetes, undiagnosed diabetes, and MetS in a coloured population 
residing in an urban suburb of Cape Town.
Methods
The study was approved by the Faculty of Health and Wellness 
Sciences ethics committee of the Cape Peninsula University of 
Technology, and was conducted according to the Code of Ethics of 
the World Medical Association (Declaration of Helsinki). Participants 
signed written informed consent after the procedures had been fully 
explained in the language of their choice. Permission was also sought 
from other relevant authorities to operate in the community and also 
to make use of designated places such as community halls and nearby 
schools for data and samples collection.
Research setting, research design and study population
A detailed description of the research setting has been described.6,10 
Bellville South is a predominantly coloured-populated area in the 
Objective. The coloured population has the second-highest 
prevalence of diabetes in South Africa. However, the data were 
based on a study conducted almost 20 years ago in a peri-urban 
coloured population of the Western Cape. We aimed to determine 
the prevalence of diabetes mellitus and metabolic syndrome in an 
urban coloured population in South Africa.
Design. In a cross-sectional survey, 642 participants aged ≥31 
years were drawn from an urban community of Bellville South, 
Cape Town, from mid-January 2008 to March 2009. Type 2 
diabetes was assessed according to the WHO criteria, and metabolic 
syndrome was based on the International Diabetes Federation 
(IDF), ATP III and 2009 Joint Interim Statement (JIS) definition.
Results. The crude prevalence of 28.2% (age-adjusted 26.3%, 
95% confidence interval (CI) 22.0 - 30.3) for type 2 diabetes was: 
4.4% (age-adjusted 3.2%, 95% CI 1.6 - 4.9) for impaired fasting 
glycaemia, and 15.3% (age-adjusted 15.0%, 95% CI 11.4 - 18.6) 
for impaired glucose tolerance. Undiagnosed type 2 diabetes was 
present in 18.1% (age-adjusted 16.8%, 95% CI 13.3 - 20.4). The 
crude prevalence of metabolic syndrome was higher with the 
JIS definition (62.0%) than the IDF (60.6%), and the National 
Cholesterol Education Program (NCEP) ATP III (55.4%). There 
was good overall agreement between the MetS criteria, k=0.89 (95% 
CI 0.85 - 0.92).
Conclusion. The prevalence of diabetes has increased hugely in 
the coloured community, and the high prevalence of undiagnosed 
diabetes portends that cardiovascular diseases might grow to 
epidemic proportions in the near future in South Africa.
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northern suburbs of Cape Town, in the Tygerberg sub-district. 
Our target population was subjects ≥31 years old. Using a map of 
Bellville South, random sampling was approached as follows: the 
area was divided into 6 strata; within each stratum the streets were 
classified as short (<22 houses), medium (23 - 40 houses) and long 
(>40 houses), based on the number of houses. Two of each street type 
were randomly selected from each stratum. Where the number of 
houses was too few, a short or a medium street was randomly selected 
and added to the stratum. The result was a total of 16 short streets 
representing approximately 190 houses, 15 medium (approximately 
410 houses) and 12 long streets (approximately 400 houses). From 
the selected streets, all household members meeting the selection 
criteria were invited to participate. Of subjects who met the criteria, 
1 000 were approached and 642 participated. The data were collected 
between mid-January 2008 and March 2009.
Data collection
A detailed protocol describing data collection procedures 
(questionnaires and physical examination) was developed. Team 
members comprising professional nurses and the recruitment team 
were trained, and a pilot study in a neighbouring community with 
similar demographics was performed to validate the questionnaire 
and to synergise the workflow. A supervisor for each team monitored 
their performance and was responsible for calibrating equipment 
according to a standard protocol. A weekly meeting was also held 
to assess progress, solve problems and re-train the research team. 
A questionnaire designed to retrospectively obtain information 
on lifestyle factors such as smoking and alcohol consumption, 
physical activity, diet, family history of CVD and diabetes mellitus, 
demographics, etc. was administered by trained personnel. The 
questionnaire was adapted from standard and recognised sources,11,12 
and was pretested in a neighbouring community with similar 
demographics. A detailed drug history was also obtained by 
interrogation and by examining the clinic cards and the record of 
drugs that participants brought to the study site.
Clinical measurements included height, weight, hip and waist 
circumferences and blood pressure. Measurements were carried 
out by qualified healthcare professionals who underwent training 
to standardise all measurements before commencing the study. 
Blood pressure measurements were performed according to WHO 
guidelines.13 Weight was determined on a calibrated and standardised 
Sunbeam EB710 digital bathroom scale. Weight measurements 
were recorded to the nearest 0.1 kg and taken with each subject 
in light clothing, without shoes and socks. Height was recorded in 
centimetres to one decimal place using a stadiometer. Body mass 
index (BMI) was calculated as weight per square meter (kg/m2). 
Using a non-elastic tape, waist circumference was measured at 
the narrowest part of the torso as seen from the anterior view and 
hip circumference around the widest segment of the buttocks. All 
anthropometric measurements were performed 3 times, and the 
average measurements were used for analysis.
All participants except the self-reported type 2 diabetes subjects 
(confirmed by either medical card record or drugs in use) underwent 
a 75 g oral glucose tolerance test (OGTT) as prescribed by the 
WHO, with fasting blood glucose. Categories of glucose tolerance 
were defined applying the 1998 WHO criteria.14 Blood samples were 
transported daily in an ice-pack box for processing at the Metropolis 
Private Pathology Laboratory (Century City, Cape Town). Plasma 
glucose was measured by enzymatic hexokinase method (Cobas 
6000, Roche Diagnostics). Glycosylated haemoglobin (HbA1c) was 
assessed by turbidimetric inhibition immunoassay (Cobas 6000, 
Roche Diagnostics). This method is National Glycohaemoglobin 
Standardisation Programme (NGSP) certified according to Roche 
Diagnostics. High-density lipoprotein cholesterol (HDL-c) and 
triglycerides (TG) were estimated by enzymatic colorimetric 
methods (Cobas 6000, Roche Diagnostics). Low-density lipoprotein 
cholesterol (LDL-c) was calculated using Friedewald’s formula. 
Serum cotinine was measured by chemiluminescent assay (Immulite 
1000, Siemens). The JIS,9 IDF8 and ATP III8 statements were used to 
define metabolic syndrome.
Statistical analysis
Statistical analysis of the data was performed using the statistical 
package R (version 2.13.0 [2011-04-13], The R Foundation for 
Statistical Computing, Vienna, Austria). The continuous variables 
are presented as medians (25th, 75th quartile range) and categorical 
variables in percentages. For data where the normality assumptions 
were suspect, the Mann-Whitney U-test was used. The chi-square test 
was used for comparison of categorical variables. Logistic regression 
was used to determine the adjusted odds ratio for type 2 diabetes 
by adjusting for other factors such as age, gender, family history of 
type 2 diabetes, alcohol consumption, serum cotinine levels, waist 
circumference or BMI, waist-to-hip ratio, hypertension, education 
status and lipid levels. Final predictors were based on backward 
elimination procedures. The age-standardised frequencies were 
calculated in 10-year intervals using the standard world population 
distribution as projected by the WHO for 2000 - 2025.15 The direct 
standardisation was applied. For the purpose of comparing the JIS, 
ATP III, and IDF definitions to identify subjects with MetS, the kappa 
(k) statistic was calculated. Results were considered significant where 
p<0.05.
Results
A total of 642 random subjects with a mean age (standard deviation) 
of 50.9 (9.1) years participated. Seventy-nine (32 males and 47 
females) subjects had previously diagnosed type 2 diabetes, and these 
subjects were not included for the prevalence of metabolic syndrome. 
The general characteristics and the prevalence of metabolic syndrome 
of the remaining 563 subjects are presented in Table 1, and data 
are presented as median (25th, 75th percentiles). The BMI, waist 
circumference, blood glucose, total cholesterol and HDL-c were 
significantly higher in females, while blood pressure and LDL-c were 
significantly higher in males.
The crude prevalence of type 2 diabetes including the previously 
diagnosed type 2 diabetes was 28.2% (age-adjusted 26.3% (95% 
confidence interval (CI) 22.0 - 30.3)), and that of undiagnosed type 2 
diabetes was 18.1% (age-adjusted 16.8% (13.3 - 20.4). Prediabetes (i.e. 
impaired fasting glucose (IFG)) was 4.4% (age adjusted 3.2% (1.6 - 
4.9), impaired glucose tolerance (IGT) was 15.3% (age adjusted 15.0% 
(11.4 - 18.6)), and the combination of both IFG/IGT was 4.3% (age 
adjusted 3.6% (2.5 - 5.2)). While prediabetes was present in subjects 
<40 years old in both sexes, type 2 diabetes was absent in males in 
this age group. In both sexes type 2 diabetes peaked at ages 40 - 49 
years, but above age 60 years, the prevalence of undiagnosed type 2 
diabetes in males was 2.6 times lower than that in females (Table 2). 
In multivariable models, increasing age (odds ratio (OR) 1.01; 95% 
CI 1.01 - 1.02, per year increase in age), waist circumference (1.01 
(1.00 - 1.01)), TG (1.06 (1.02 - 1.10)), and family history of diabetes 
(1.17 (1.09 - 1.26)) were significantly associated with both diabetes 
mellitus and prediabetes.
Overall, there was a good agreement between the MetS criteria 
(k=0.89, 95% CI 0.85 - 0.92), between JIS and IDF (0.97; 0.95 - 0.99), 
JIS and ATP III (0.86; 0.82 - 0.90) and IDF and ATP III (0.83; 0.79 - 
0.88). In the group of 558 subjects included in the determination of 
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Table 1. Characteristics of 563 participants, stratified by gender
Characteristics Male (n=109) Female (n=454) p-value
Age (years) 52 (44, 59) 51 (43, 48) 0.33
BMI (kg/m2) 25.8 (22.3, 30.0) 30.8 (26.5, 35.4) <0.0001
Waist-C (cm)* 94 (81, 105) 98.5 (88, 108) <0.0001
WHR 0.93 (0.87, 0.98) 0.87 (0.82, 0.92) <0.0001
SBP (mmHg)* 123 (114, 133) 118 (108, 130) 0.013
DBP (mmHg)* 77 (69, 85) 74 (67, 82) 0.016
FBG (mmol/l) 5.5 (5.0, 7.0) 5.6 (5.0, 6.4) 0.948
PostBG (mmol/l) 6.3 (5.3, 8.3) 6.9 (5.7, 8.8) 0.014
HbA1c (mmol/mol) 40 (37, 50) 41 (37, 45) 0.2245
HbA1c (%) 5.8 (5.5, 6.7) 5.9 (5.5, 6.3) 0.779
TC (mmol/l) 5.42 (4.75, 6.08) 5.63 (4.85, 6.45) 0.007
TG (mmol/l) 1.36 (0.95, 1.91) 1.29 (0.93, 1.83) 0.379
HDL-c (mmol/l) 1.13 (0.96, 1.40) 1.22 (1.02, 1.44) 0.027
LDL-c (mmol/l) 3.34 (2.66, 4.12) 3.73 (3.07, 4.40) 0.0004
Current smoking % 57.8 41.2 0.0017
Serum cotinine (ng/ml) 24 (9, 325) 9 (9, 327) 0.345
Alcohol consumption % 53.2 22.5 <0.0001
MetS JIS (n=558) 38 (35.2%) 308 (68.4%) <0.0001
MetSNCEP ATP III (n=558) 29 (26.8%) 280 (62.2%) <0.0001
MetSIDF (n=558) 33 (30.6%) 305 (67.8%) <0.0001
*replicated measurements; Waist-C = waist circumference; WHR = waist-to-hip ratio; SBP = systolic blood pressure; DBP = diastolic blood pressure; FBG = fasting blood glucose; PostBG = post 
2-hour blood glucose; TC = total cholesterol; TG = triglyceride; HDL-c = high-density lipoprotein cholesterol; LDL-c = low-density lipoprotein cholesterol; IDF = International Diabetes Federation; 
JIS = Joint Interim Statement; MetS = metabolic syndrome; NCEP ATP III = National Cholesterol Education Program, Adult Treatment Panel III.
Table 2. Age-specific frequency of undiagnosed type 2 diabetes according to the WHO criteria among the coloured population of 
South Africa. Frequencies are expressed as percentages
Age groups (n) Prevalence IFG IGT IFG/IGT
Undiagnosed
diabetes
30 - 39 (12 M, 65 F)
Men; women 8.3; 6.2 16.7; 13.8 0; 0 0; 7.7
Crude, overall 6.5 14.3 0 6.5
Age-adjusted 2.7 (0.1 - 5.3) 14.2 (8.6 - 19.8) 0 6.8 (2.7 - 10.8)
40 - 49 (39 M, 159 F)
Men; women 5.1; 5.0 12.8; 11.9 0; 4.4 20.5; 15.7
Crude, overall 5.1 12.1 3.5 14.7
Age-adjusted 4.8 (1.0 - 8.5) 11.9 (6.2 - 17.6) 3.2 (0.1 - 6.2) 15.9 (9.5 - 22.2)
50 - 59 (41 M, 137 F)
Men; women 2.4; 5.1 12.2; 20.4 2.4; 5.1 17.1; 19.7
Crude, overall 4.5 18.5 4.5 16.8
Age-adjusted 4.0 (0.2 - 7.9) 18.2 (10.6 - 25.8) 4.0 (0.2 - 7.9) 19.2 (11.4 - 26.9)
>60 (17 M, 93 F)
Men; women 0; 2.2 29.4; 14.0 5.9; 8.6 11.8; 31.2
Crude, overall 1.8 16.4 8.2 28.2
Age-adjusted 1.7 (0.6 - 4.0) 16.7 (10.0 - 23.3) 8.3 (3.4 - 13.3) 28.3 (20.3 - 36.4)
Total 563
Crude prevalence 4.4 15.3 4.3 18.1
Age-adjusted 3.2 (1.6 - 4.9) 15.0 (11.4 - 18.6) 3.6 (2.5 - 5.2) 16.8 (13.3 - 20.4)
F = female; IFG = impaired fasting glycaemia; IGT = impaired glucose tolerance; M = male.
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MetS, the crude prevalence of MetS was higher with the JIS definition 
(62.0%) than the IDF (60.6%) and the NCEP ATP III (55.4%). 
Irrespective of the method used, MetS was significantly more 
prevalent in females (p<0.0001 (Table 1)). Central obesity was the 
most common abnormal criterion, followed by raised blood pressure, 
reduced HDL-c, hyperglycaemia and raised TG. MetS increased with 
age; 81.2% of subjects with undiagnosed type 2 diabetes, and 83.7% 
with non-diabetic hyperglycaemia, had MetS, compared with 46.9% 
normoglycaemic subjects using the JIS criteria.
Discussion
We provide evidence that the mixed ancestry population of the 
Western Cape is experiencing the predicted diabetes epidemic in 
developing countries. In contrast to the last report published 12 years 
ago in a peri-urban coloured population of the Western Cape,2 we 
found a high prevalence (28.2%) of type 2 diabetes, which included 
80 previously diagnosed type 2 diabetes and 101 undiagnosed type 
2 diabetes subjects. The age-adjusted prevalence of type 2 diabetes 
(26.3%) was very high compared with the 2010 estimates for adults 
aged 20 - 79 years from South Africa, but similar to Nauru which has 
one of the highest prevalence rates in the world.16 The sharp increase 
in the prevalence of type 2 diabetes between these studies may be 
due to the geographical location of these populations, significant 
differences in obesity, their economic transition, and the different 
criteria used for diagnosing diabetes. The limited studies in South 
Africa have shown a positive rural-to-urban gradient in terms of 
the prevalence of type 2 diabetes,2-4,12 and the sample for this study 
was taken from an urban coloured population located approximately 
50 km from the previous study.2 Furthermore, our study subjects 
were more obese, with larger waist circumferences. The mean 
waist circumference was 98.5 cm in females and 94.0 cm in males, 
resulting in 87.9% and 42.2% central obesity rates as defined by the 
IDF criteria, respectively. Waist circumference together with family 
history of type 2 diabetes, TG and increasing age, were significantly 
associated with the development of diabetes mellitus.
Despite the availability of primary healthcare, 101 (55.8%) out of 
181 subjects with type 2 diabetes were not aware of their condition. 
These findings suggest that the primary healthcare system may be 
inadequate to identify type 2 diabetes cases and those at high risk 
of type 2 diabetes. Individuals with undiagnosed type 2 diabetes or 
pre-diabetes exhibit a high prevalence of MetS and are therefore at a 
higher future risk of CVD. Though the prevalence of MetS was lower 
when using the ATP III definition than the IDF and the JIS, there was 
generally good concordance between all three MetS criteria. To our 
knowledge, this is the first population-based report on the prevalence 
of MetS in the coloured population and is the highest observed 
among sub-Saharan populations.8,17 The JIS definition for identifying 
subjects with MetS has been used in very few studies from Africa.17 
Compared with other sub-Saharan regions that used IDF or ATP III,8 
our study prevalence of MetS was much higher, probably reflecting the 
high diabetes prevalence in our population. Irrespective of the MetS 
definition used, we observed MetS to be significantly more prevalent 
in females, a difference unquestionably due to the increased central 
obesity in females.
There are a few limitations to this study. On account of logistic 
constraints, blood glucose measurements were not repeated in 
asymptomatic subjects who were found to have pre-diabetes or type 2 
diabetes, as has been previously suggested.14 The nature of this study 
is cross-sectional, with high female-to-male participation, which is a 
common trend in South African population studies.
In conclusion: our data are consistent with literature demonstrating 
a strong association between MetS and type 2 diabetes. Contrary to 
previous reports, the coloured population of South Africa has a 
high CVD risk, as shown by the high prevalence of type 2 diabetes 
accompanied by MetS. This finding emphasises the need for South 
Africa to reorganise its primary healthcare system to manage chronic 
lifestyle diseases and curb this new epidemic alongside the existing 
infectious disease burden.
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